Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Evelo Biosciences

Insiders Buy More Than $41M Of 2 Penny Stocks

US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga · Jun 2, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · Jun 1, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · May 25, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Evelo Biosciences: Q1 Earnings Insights

Evelo Biosciences (NASDAQ:EVLO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

Read Why Did Evelo Discontinue EDP1867 Atopic Dermatitis Program

Evelo Biosciences Inc (NASDAQ:EVLO) will put the EDP1867 program on hold after completing a Phase 1 clinical trial in atopic dermatitis. Data from the Phase 1b clinical trial of EDP1867 (n=52, with 40 participants who had at least one dose of EDP1867) showed it was safe and well-tolerated in both healthy volunteers and…

Benzinga · Apr 14, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga · Mar 24, 2022

Evelo Biosciences Shares Gain After Positive Data On Faster Release EDP1815 Capsule, Q4 Earnings

In the Q4 earnings release, Evelo Biosciences Inc (NASDAQ:EVLO) shared results from an ongoing Phase 1 single-center trial in healthy volunteers that showed that a capsule with an improved release profile could deliver EDP1815 higher up in the small intestine.

Benzinga · Mar 24, 2022

Read news from The Economist, FT, and more,
with one subscription

Evelo Biosciences: Q4 Earnings Insights

Evelo Biosciences (NASDAQ:EVLO) reported its Q4 earnings results on Thursday, March 24, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 24, 2022

Evelo Biosciences's Earnings Outlook

Evelo Biosciences (NASDAQ:EVLO) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that Evelo Biosciences will report an earnings per share (EPS) of $-0.61.

Benzinga · Mar 23, 2022

Evelo Biosciences Q4 2021 Earnings Conference Call On March 24, 2022 At 08:30 AM ET

Evelo Biosciences (NASDAQ:EVLO) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend Evelo Biosciences (EVLO) Conference Call Follow this link to access the live webcast.

Benzinga · Mar 18, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

421,934 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.